The largest database of trusted experimental protocols

Monosomy

Monosomy refers to the genetic condition where an individual is missing one chromosome from a pair.
This chromosomal abnormality can lead to a range of developmental and health issues, depending on the specific chromosome involved.
Monosomies are rare, but understanding their underlying mechanisms and impacts is crucial for advancing research and clinical care in this field.
PubCompare.ai can help optimize monosomy studies by providing access to cutting-edge protocols from literature, preprints, and patents, while utilizing AI-driven comparisons to identify the most effective methods and products.
This powerful tool can enhance the reproducibility and accuaracy of monosomy research, supporting scientific progress in this important area of genetic and medical study.

Most cited protocols related to «Monosomy»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2015
Centrifugation Codon Monosomy Nematoda Ribonuclease, Pancreatic Ribosomes Sucrose Yeast, Dried

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Buffers Cells DNA, Complementary Endoribonucleases Filtration Freezing Guanylyl Imidodiphosphate Magnesium Chloride Monosomy Nitrogen Reproduction Reverse Transcription Ribosomal RNA Ribosomes RNA, Messenger Saccharomyces cerevisiae Stabilizing Agents Sucrose Triton X-100 Tromethamine Vacuum
Indexed paired-end .qseq files were aligned to the mouse reference genome (mm9) using bwa31 (link), and custom scripts were used to split the resulting .bam files by index and to add the chastity flag. The resulting .bam files were sorted and filtered for duplicates (which removes both single-end and dual-end duplicates) and low-quality alignments (q < 20) using Samtools Version 0.1.10 (ref. 32 (link)). We developed a pipeline, BAIT (bioinformatic analysis of inherited templates), that parsed the bam files on the basis of the strand directionality assigned to each read. Reads that mapped to the ‘+’ strand from the first PET (paired-end tag) and the ‘−’ strand reads from the second PET were classified as Watson reads, and reads that mapped to the – strand from the first PET and the + strand from the second PET were classified as Crick reads. These data were plotted as separate histograms against ideograms of mouse chromosomes, with reads counted in 200-kb bins across each chromosome. Additional files in .bed format were plotted over the ideograms to represent sequence gaps and contig orientations. The number of reads mapping to Watson or Crick for each chromosome were summed, and the number of reads per megabase for each chromosome was calculated and printed below the ideograms. Normalized counts per megabase were determined by calculating the sum of both Watson and Crick reads for all autosomes and dividing by the length of the autosomes (in megabases). Any chromosomes in which read counts were 0.66× lower or 1.33× higher than the normalized count were classified as monosomies or trisomies, respectively. SCE events were defined as the interval in which there was a switch from reads mapping to both Watson and Crick strands to reads mapping to just one of the strands, without a corresponding change in the total number of reads such that the sum of Watson and Crick reads remained constant. Our criteria further stipulated that there must be ten consecutive Watson-only or Crick-only reads after the interval switch to count the switch as an SCE or to confirm fragment or contig orientation. To verify SCE and misorientation events, the SCE and misoriented contig interval coordinates were also converted to .bed files using BEDtools33 (link) and uploaded to the UCSC genome browser to identify genomic features and genome build features, such as contigs, and to determine suitable BACs for FISH probes.
Publication 2012
Chromosomes Fishes Genome Mice, House Monosomy Trisomy
Patients treated on recent COG AML trials (5 (link)–7 (link)), who achieved an initial remission, had a subsequent relapse, and a diagnostic blast percentage >50% were selected for this study. These clinical trials randomized type and timing of induction therapy (CCG-2961) and randomized additions to backbone therapy (AAML03P1 and AAML0531) but did not include molecularly-targeted treatment. All karyotypes were centrally reviewed, and patients with high-risk cytogenetic features (monosomy 7, monosomy 5 or del5q) were excluded. Selected molecular features (e.g. KIT, RAS, NPM, WT1, CEBPA, IDH1 mutations and FLT3/ITD) were clinically available (4 (link),8 (link),9 (link)).
Publication 2016
CEBPA protein, human Chromosome 7, monosomy Diagnosis FLT3 protein, human Karyotyping Monosomy Mutation Neoadjuvant Therapy Patients Relapse Vertebral Column
For both BF and PF, 200 µl aliquots of the lysate (OD260 = 40) were digested with RNase I (Ambion) at RT (1200 units) or on ice (1600 units). After 1 h, the digestions were stopped by adding 100 units of SUPERase•In RNase inhibitor (Ambion) to the RNase-treated samples. In parallel, 100 units of SUPERase•In RNase inhibitor were added to a 200 µl aliquot of lysate not containing RNase I (undigested control). Monosomes were purified using sucrose gradients as described previously (45 (link)).
Total RNA from undigested lysates and the footprints collected in the monosome fractions were purified using hot acid Phenol–Chloroform–Isoamyl alcohol (v/v/v 25:24:1) at 65°C (49 (link)). To generate mRNA sequencing libraries, undigested RNA was polyA-enriched using a Dynabeads® mRNA Purification Kit (Ambion) according the manufacturer’s instructions. The polyA-enriched RNA was fragmented by incubation with an RNA Fragmentation Reagent (Ambion) at 70°C for 30 min. Successful fragmentation was monitored on a 15% denaturing-PAGE gel. Both, ribosome footprints and fragmented mRNA (26–34 nt) were size-selected by electrophoresis using a 15% denaturing-PAGE gel and two custom-made (IDT) synthetic RNA markers [5′-AUGUACACGGAGUCGAGCUCAACCCGCAACGCGA-(Phos)-3′] and [5′-AUGUACACGGAGUCGACCCAACGCGA-(Phos)-3′].
Sequencing libraries were prepared as described (50 (link)) except for the omission of an rRNA depletion step during the footprint library preparation and the use of KAPA HiFi polymerase (Kapa Biosystems) for the final amplification step.
Full text: Click here
Publication 2014
Acids Chloroform Digestion DNA Library Electrophoresis isopentyl alcohol Monosomy Phenol Poly A Ribonuclease, Pancreatic Ribonucleases Ribosomal RNA Ribosomes RNA, Messenger RNA, Polyadenylated Sucrose

Most recents protocols related to «Monosomy»

Aneuploidy was defined as a loss or gain of the genetic material of chromosome(s), including monosomies, trisomies, polyploidies, segmental aneuploidies, and complex chromosome aneuploidies. In this study, aneuploidy rate of of SA-CV was compered between D5 group and D6 group. Other factors such as age, type of infertility, diagnosed with PCOS were assessed to see if they affected chromosomal results.
Full text: Click here
Publication 2023
Aneuploidy Chromosomes Genetic Materials Monosomy Polycystic Ovary Syndrome Polyploidy Sterility, Reproductive Trisomy
After labeling cells were quickly washed in ice-cold PBS before being scraped in mt-polysome lysis buffer (0.25% Lauryl Maltoside, 10mM Tris pH 7.5, 0.5mM DTT, 20 mM magnesium chloride, 50 mM ammonium chloride 1× EDTA-free protease inhibitor cocktail (Roche)). Cell lysates were dounced 7 times in a 1mL dounce with the tight piston and then flash frozen. 1mL of thawed lysate was clarified by spinning twice at 10,000 rcf. To avoid contamination of nascent RNA still attached to mtDNA into the higher molecular weight sucrose gradient fractions we digested all DNA by 150 units of DNAse I (NEB) in the presence of superaseIn (ThermoFisher) and 0.5mM calcium chloride at room temperature for 1 h. To isolate mitoribosomes, lysates were loaded on 10–50% linear sucrose gradients and centrifuged in a Beckman ultra-centrifuge at 40,000 RPM for 3 h at 4°C using a SW41Ti rotor. Some of the input for the sucrose gradient fractionation was kept and treated as a standard sample described above. Gradients were mixed and fractionated using a BioComp instrument. To identify the mitoribosome containing fractions we western blotted for Mrpl12 (Proteintech 14795–1-AP) and Mrps18B (Proteintech 16139–1-AP) as described below. Monosomes and polysomes containing fractions were pooled and the mitoribosomes were immunoprecipitated out of the pooled fractions. For the immunoprecipitation, MRPL12 antibodies were conjugated to Protein A dynabeads (ThermoFisher) for 1 h in mt-polysome lysis buffer. After washing the beads, lysates were added and incubated for 3 h at 4C. After 3 h the supernatant was removed and the beads were washed three times in mt-polysome lysis buffer before the mitoribosomes were eluted in 0.2% SDS, 100 mM NaCl, 10 mM Tris pH 7.5, 1X EDTA-free protease inhibitor cocktail and SuperaseIn. IP efficiency was confirmed by western blotting as described below. RNA was extracted from the eluates using Trizol LS as described above and then further cleaned by using 1.8x volume of RNAClean XP beads (Beckman Coulter A63987) and washed in 80% ethanol.
When collecting RNA, from NT or FASTKD5 KD cells, destined for direct RNA-sequencing on the nanopore two gradients per condition were used as input for the IP and the final clean-up step using RNAClean XP beads was omitted.
Publication Preprint 2023
Antibodies Buffers Calcium chloride Cells Chloride, Ammonium Cold Temperature Deoxyribonuclease I DNA, Mitochondrial dodecyl maltoside Edetic Acid Ethanol Freezing Immunoprecipitation Magnesium Chloride Mitochondrial Ribosomes Monosomy Polyribosomes Protease Inhibitors Radiotherapy Dose Fractionations Sodium Chloride Staphylococcal Protein A Sucrose trizol Tromethamine
Each 5,000 U total ribosomes were digested by 1,500 U RNase I (Ambion, AM2294) for RF generation. The digested solutions were separated by profiling as described in the polysome profiling experiments. We added 2 volume 8 M guanidine hydrochloride, 3 volume ethanol, and 2 µL GlycoBlue (Ambion, AM9516, 15 mg/mL) into monosome fractions for RNA extraction. The ~28-nt RFs were separated with Urea-PAGE, and rRNA was removed using DNA probes complementary to rRNA sequences. Then, RNase H and DNase I were used to digest the probes. RFs were purified using magnet beads (Vazyme). After obtaining RFs above, Ribo-seq libraries were constructed using NEBNext Multiple Small RNA Library Prep Set for Illumina (catalog no.E7300S, E7300L). Briefly, adapters were added to both ends of RFs, followed by reverse transcription and PCR amplification. The 140 to 160-bp size PCR products were enriched to generate a cDNA library and sequenced using Illumina HiSeqTM 2500 by Gene Denovo Biotechnology Co.
Full text: Click here
Publication 2023
cDNA Library Deoxyribonuclease I DNA Library Ethanol Genes Hydrochloride, Guanidine Monosomy Polyribosomes Reverse Transcription Ribonuclease, Pancreatic Ribonuclease H ribonuclease U Ribosomal RNA Ribosome Profiling Ribosomes Urea
Data was collected from our local ocular oncology database, retrospective analysis of electronic notes and review of patient charts. Patients included for analysis were those that presented to the ocular oncology service from January 2019 to December 2020 in the Royal Victoria Eye and Ear Hospital in Dublin, who underwent primary treatment for uveal melanoma—proton beam therapy, brachytherapy or enucleation. Information was collected regarding patient demographics (age, gender, smoking status, ethnicity), clinical features (laterality—right or left, site of uveal melanoma, e.g. ciliochoroidal/juxta-papillary/choroidal, basal diameter and thickness, date of presentation, date of primary treatment, primary treatment received, e.g. proton beam, brachytherapy or enucleation, plaque duration and type, presence or absence of extra-scleral extension upon enucleation) as well as chromosomal and histological features, e.g. cell type, disomy/monosomy 3, BAP 1. Excluded for analysis were patients that presented to our service prior to January 2019 or after December 2020, patients with non-uveal ocular melanomas, e.g. conjunctival melanomas, those undergoing conservative/observational or palliative management, those refusing treatment and exenterations for orbital tumours. A diagnosis of uveal melanoma was made based on clinical features and examination findings from a dilated fundus examination and multimodal imaging consisting of colour fundus photography, optical coherence tomography and B-scan ultrasonography. An ocular oncology specialist formulated a treatment plan in consultation with a multidisciplinary team. DNA mutations in the BAP1 gene were evaluated by immunohistochemical staining of formalin-fixed paraffin-embedded sections. Uveal material was tested for loss of chromosome 3 and gain of chromosome 8q gene signatures by selective molecular gene markers using multiplex ligation-dependent probe amplification (MLPA). Statistical analyses were conducted using SAS JMP data analysis software Version 16.1.0. Categorical variables were analysed using χ2 tests and continuous variables were analysed using the Kruskal–Wallis and Mann–Whitney tests, using a two-tailed significance level of P < 0.05.

Summary of uveal melanoma characteristics and demographics, 2019 and 2020

20192020
Sex N (%)
  Female15 (32.6)20 (39.2)
  Male31 (67.4)31 (60.8)
  Total46 (100)51 (100)
  Age, mean ± SD61.1 ± 11.161.2 ± 12.8
Source of referral N (%)
  Casualty1 (2.2)7 (13.7)
  Diabetic screening1 (2.2)0 (0)
  Optician2 (4.3)2 (4.3)
  Ophthalmologist42 (91.3)40 (78.4)
Tumour dimension, mean ± SD
  Basal diameter (mm)11.8 ± 4.013.4 ± 3.9
  Thickness (mm)4.8 ± 2.76.6 ± 3.5
  Primary treatment N(%)
  Proton beam therapy12 (12.4)6 (6.2)
  Brachytherapy25 (25.8)24 (24.7)
  Enucleation9 (9.3)21 (21.6)
  Presence of extra-scleral extension0 (0)4 (4.1)
Time from presentation to treatment (mean ± SD)
  Overall (days)35.6 ± 28.824.1 ± 20.4

Uveal melanoma: mean basal diameter and tumour thickness (mm) in 2019 and 2020

Full text: Click here
Publication 2023
Biological Markers Brachytherapy Cells Choroid Chromosomes Chromosomes, Human, Pair 3 Conjunctiva Dental Plaque Diagnosis Ethnicity Eye Formalin Functional Laterality Gender Genes MAGI1 protein, human Melanoma Monosomy Multiplex Ligation-Dependent Probe Amplification Mutation Neoplasms Orbital Neoplasms Paraffin Embedding Patients Protons Proton Therapy Radionuclide Imaging Sclera Tomography, Optical Coherence Ultrasonography Uvea Uveal melanoma
Ribosome profiling was performed as previously described26 (link). After RNase treatment, testis lysates were loaded on a 10–50% (w/v) linear sucrose gradient and after centrifugation the fractions corresponding to 80S monosomes were recovered. rRNA fragments were removed as previously described75 .
Full text: Click here
Publication 2023
Centrifugation Monosomy Ribonucleases Ribosomal RNA Sucrose Testis

Top products related to «Monosomy»

Sourced in United States, Germany, China, Canada
RNase I is an enzyme that cleaves single-stranded RNA molecules. It is widely used in molecular biology laboratories for various applications, such as the removal of RNA from DNA samples.
Sourced in United States, Canada, Germany, France
The SW41Ti rotor is a swinging-bucket ultracentrifuge rotor designed for high-speed separation and analysis of macromolecules and subcellular organelles. It is capable of reaching a maximum speed of 41,000 revolutions per minute (rpm) and can generate a maximum relative centrifugal force (RCF) of 274,000 x g. The rotor is well-suited for applications such as gradient separations, virus purification, and the isolation of cellular fractions.
Sourced in United States, Canada, Germany, France
The SW41 rotor is a high-speed centrifuge rotor designed for Beckman Coulter ultracentrifugation systems. It is capable of reaching a maximum speed of 41,000 revolutions per minute (rpm) and can generate a maximum relative centrifugal force (RCF) of 274,000 x g. The SW41 rotor is commonly used for the separation and purification of various biological samples, such as proteins, nucleic acids, and organelles.
Sourced in Canada
The Gradient Station is a laboratory instrument designed for generating linear gradients. It enables the creation of precise and consistent gradient solutions for various applications in scientific research and analysis.
Sourced in United States
Superase-In is a ribonuclease inhibitor that protects RNA from degradation during sample preparation and analysis. It is a concentrated, recombinant, and animal-free product designed for use in sensitive RNA applications.
Sourced in United States, China, Germany, United Kingdom, Canada, Switzerland, Sweden, Japan, Australia, France, India, Hong Kong, Spain, Cameroon, Austria, Denmark, Italy, Singapore, Brazil, Finland, Norway, Netherlands, Belgium, Israel
The HiSeq 2500 is a high-throughput DNA sequencing system designed for a wide range of applications, including whole-genome sequencing, targeted sequencing, and transcriptome analysis. The system utilizes Illumina's proprietary sequencing-by-synthesis technology to generate high-quality sequencing data with speed and accuracy.
Sourced in United States
CircLigase is a proprietary DNA ligase enzyme designed for circularizing nucleic acid molecules. It catalyzes the formation of a phosphodiester bond between the 5' phosphate and 3' hydroxyl groups of single-stranded DNA or RNA, allowing for the creation of closed circular constructs.
Sourced in United States, Germany, United Kingdom, China, Italy, Sao Tome and Principe, France, Macao, Japan, Spain, Canada, Switzerland, India, Israel, Brazil, Poland, Portugal, Australia, Morocco, Sweden, Austria, Senegal, Belgium
Cycloheximide is a laboratory reagent commonly used as a protein synthesis inhibitor. It functions by blocking translational elongation in eukaryotic cells, thereby inhibiting the production of new proteins. This compound is often utilized in research applications to study cellular processes and mechanisms related to protein synthesis.
Sourced in Canada, United States
The Econo UV Monitor is a compact and efficient device designed to continuously monitor the ultraviolet (UV) absorbance of liquids flowing through a chromatography system. It provides real-time data on the UV absorption of the sample, which can be used to identify the presence and concentration of specific compounds. The Econo UV Monitor is a reliable and versatile tool for various applications in analytical and preparative chromatography.
Sourced in United States, Germany
The SW40Ti rotor is a high-performance ultracentrifuge rotor designed for Beckman Coulter's line of ultracentrifuges. It is capable of reaching speeds up to 40,000 revolutions per minute (rpm) and can generate centrifugal forces up to 267,000 x g. The rotor is made of titanium and is suitable for a variety of applications, including density gradient separations, organelle isolation, and macromolecule purification.

More about "Monosomy"

Chromosomal Abnormalities and Monosomy: Unveiling the Complexities Monosomy, a rare but critical genetic condition, refers to the absence of one chromosome from a pair.
This chromosomal anomaly can lead to a wide range of developmental and health issues, depending on the specific chromosome involved.
Understanding the underlying mechanisms and impacts of monosomies is crucial for advancing research and clinical care in this important field.
Explore the insights and tools available to optimize your monosomy studies.
PubCompare.ai is a powerful platform that can help you locate cutting-edge protocols from the literature, preprints, and patents, while utilizing AI-driven comparisons to identify the most effective methods and products.
This can enhance the reproducibility and accuracy of your monosomy research, supporting scientific progress in this area of genetic and medical study.
Delve deeper into the complexities of monosomy by familiarizing yourself with related terms and concepts.
Discover how techniques like RNase I, SW41Ti rotor, SW41 rotor, Gradient Station, Superase-In, HiSeq 2500, CircLigase, Cycloheximide, and Econo UV Monitor can contribute to your research.
Stay ahead of the curve and explore the latest advancements in this captivating field of genetic and medical inquiry.
By leveraging the insights and tools available, you can elevate your monosomy research to new heights, driving scientific progress and improving our understanding of this rare but impactful chromosomal abnormality.
Embark on a journey of discovery and unlock the secrets of monosomy, one step at a time.